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excitotoxicity. In the present work, we investigated the putative neuroprotective role of 
ketamine, an NMDA receptor antagonist, on early life SE-induced acute neuronal death and 
long-term behavioral abnormalities. Male Wistar rats (16 postnatal days) were induced to SE by 
LiCl–pilocarpine i.p. administration (3 mEq/kg; 60 mg/kg, respectively). Fifteen or 60 min after 
pilocarpine injection, animals received a ketamine administration (22.5 mg/kg i.p.). Neuronal 
degeneration was assessed 24 h after SE induction. Another subset of animals was destined to 
behavioral tasks in adulthood (75–80 postnatal days). Fluoro-Jade C labeling revealed a marked 
neuronal death on CA1 hippocampal subfield, habenula, thalamus and amygdala in SE animals. 
Ketamine post-SE onset treatment prevented neuronal death in all regions assessed. In the 
elevated plus maze, SE induced an increase in anxiety-like behaviors whereas ketamine 
administration during seizures was able to prevent this alteration. Ketamine administration 
in non-SE animals resulted in high anxiety levels. There were no observed differences among 
groups in the open field task in all parameters analyzed. Our results suggest that ketamine post-
SE onset treatment was effective in preventing acute and long-standing alterations caused by SE 
early in life, which indicates a putative role of glutamatergic system on SE-induced brain 
damage as well as long-lasting behavioral consequences.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Status epilepticus (SE) is a life-threatening neurological disorder 
defined as a seizure or repeated seizures lasting more thane Elsevier OA license.
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long-term consequences (de Oliveira et al., 2008; Fujikawa, 1995;
Kubova et al., 2004; Rice et al., 1998; Sankar et al., 1998).
One of the initial consequences of SE on the developing brain
is a rapid neuronal cell death observed in specific areas. Rats
submitted to LiCl–pilocarpine-induced SE during the first three
weeks of life presented an intense neuronal loss in hippocam-
pus, amygdala, thalamus and temporal cortical regions (such as
perirhinal and entorhinal cortices) (de Oliveira et al., 2008;
Kubova et al., 2004; Sankar et al., 1998). SE-induced nerve cell
damage was considered to occur through both necrosis and
apoptosis, whereas eosinophilic cells and nuclear fragmenta-
tion in TUNEL staining was observed in SE-submitted animals
(Kubova et al., 2004; Sankar et al., 1998).
In addition to the acute neuronal death, early life-induced
SE can cause long-standing structural and functional changes
in the brain. Young rats (until 3 weeks old) submitted to SE
presented a severe memory impairment in several tasks such
as inhibitory avoidance and water maze at adulthood (de
Oliveira et al., 2008; Hoffmann et al., 2004; Sayin et al., 2004).
Moreover, animals also displayed alterations in their emo-
tional behavior, which was characterized by higher levels of
anxiety when exposed to the light–dark box and elevated plus
maze (de Oliveira et al., 2008; Sayin et al., 2004).
SE-induced neuronal degeneration has been frequently
associated with an excessive activation of NMDA ionotropic
glutamate receptors (NMDAR) (Holopainen, 2008) and pre-
vious studies have demonstrated that pretreatment with
NMDAR antagonists is neuroprotective against SE-induced
neuronal death (Clifford et al., 1990; Fujikawa, 1995; Holmes,
2004). However, despite the treatment of patients with SE
started after onset of seizures, there are no studies investi-
gating the effects of NMDAR blockage during SE. Thus, it
becomes important to know the effectiveness of post-SE
onset treatments with NMDAR antagonists in order to avoid
the short- and long-lasting alterations induced by SE.
Therefore, the aim of this study was to investigate the
putative protective action of a post-SE onset treatment with
ketamine, a non-competitive NMDAR antagonist, on SE-
induced neuronal death as well as on long-term behavioral
alterations in animals submitted to SE early in life.2. Results
2.1. Effect of ketamine on LiCl–pilocarpine-induced SE
The convulsive pattern presented by LiCl–pilocarpine-treated
animals was similar to that described by de Oliveira et al.
(2008). Systemic administration of LiCl–pilocarpine produced
defecation, salivation, body tremor, and scratching within 2
to 8 min. This behavioral pattern progressed within 8 to
13 min to increased levels of motor activity and culminated
in SE in all animals. SE was characterized by sustained
orofacial automatisms, salivation, chewing, forelimb clonus,
loss of righting reflex and falling.
Animals treated with ketamine after SE onset presented a
distinct behavioral pattern of seizures when compared with
LiCl–pilocarpine rats. Five minutes after antagonist adminis-
tration, both groups that received ketamine at 15 min(SEþKET15) or at 60 min (SEþKET60) showed a reduction in
the intensity of sustained orofacial automatisms, forelimbs
clonus and chewing, without recovery of the loss of righting
reflex. The SE-induced motor activity was stopped only
70 min after SE onset for both ketamine-treated groups.
Ketamine when administered at doses higher than 45 mg/
kg, caused death in all SE-induced animals (data not shown).
Animals from ketamine group (KET) showed symptoms of
anesthesia, such as sedation, 2 min after ketamine adminis-
tration and were recovered 45 min later.
2.2. Effect of ketamine on SE-induced neurodegeneration
By using Fluoro-Jade C (FJC) staining in brain sections, a large
number of degenerative neuronal cells were observed in brains
from SE group (Fig. 1). The FJC-positive staining cells showed
a bright green color in the somas and fine processes with
neuronal profiles (Fig. 1 inserts). LiCl–pilocarpine administration
induced a massive neurodegeneration in several brain regions,
including CA1 hippocampal subfield, habenula (lateral habenu-
lar nucleus), thalamus (ventral posteromedial thalamic nucleus)
and amygdala (medial amygdaloid nucleus) 24 h after SE onset
(Fig. 1). Both ketamine post-SE onset treated groups presented a
significant reduction in the number of FJC-positive neurons
(85–100%) in all brain regions analyzed (Table 1). FJC-positive
neurons were not observed in brain regions from control (CTRL)
and KET groups.
2.3. Effect of SE and ketamine on locomotor and
exploratory activities
The pattern of distance traveled, and number of animals
rearing and grooming across time were similar in all groups
(Fig. 2A–C). All animals showed intra-session habituation to
apparatus approximately 7 min after the starting of the
session. There were no differences in other parameters of
locomotor and exploratory activities, temporal organization
and spatial distribution in all groups (Fig. 2D–F and supple-
mentary Fig. S1 A–F). Moreover, all groups showed a similar
pattern of inter-session habituation of the distance traveled,
and number of animals rearing and grooming during the
three days of testing (data not shown).
2.4. Effect of SE and ketamine on anxiety-like behaviors
Animals from SE and KET groups spent significantly low time
in open arms (62.9716.8 and 40.176.9, respectively; F¼6.626;
p¼0.0004) when compared to the CTRL group (150.1710.3)
(Fig. 3A). Ketamine post-SE onset treatment in both times
(SEþKET15 and SEþKET60) increased the time spent in open
arms (115.9715.3 and 101.5719.2, respectively), however
these values were not different from both CTRL and SE
groups. SEþKET15 and SEþKET60 groups, when compared
with only KET, spent more time in open arms. The number of
risk assessment behaviors was significantly increased in the
KET group (7.371.4) when compared to the CTRL and SEþKET60
groups (2.870.6 and 2.670.6, respectively) (Fig. 3B; F¼4.679;
p¼0.0038). Animals from SE (7.071.4), SEþKET15 (4.170.9),
SEþKET60 and CTRL groups presented similar levels of risk
assessment behaviors. All groups presented similar number of
Table 1 – Number of Fluoro-Jade C positive cells.
Group Brain structures
CA1 Habenula Thalamus Amygdala
CTRL NFnn NFnn NFnn NFnn
KET NFnn NFnn NFnn NFnn
SE 76.5718.5 150.5715.5 72.573.5 566.57141.5
SEþKET15 NFnn NFnn NFnn 4.772.9n
SEþKET60 3.271.5nn 22.778.3nn 8.572.3nn 60.7724.5n
one-Way ANOVA F value 36.63 69.96 242.7 28.03
one-Way ANOVA p value 0.0004 o0.0001 o0.0001 0.0009
N¼4 animals/group. NF indicates that FJC-positive cells were not found; n¼po0.01 as compared to SE group; nn¼po0.001 as compared to SE
group. All data were analyzed by One-Way ANOVA followed by Tukey post hoc test.
Fig. 1 – SE induced neurodegeneration. Coronal sections show a markedly decreased number of FJC-labeled neurons from
brain sections of SEþKET15 and SEþKET60 treated animals when compared with SE animals. Area between the dashed lines
represents the CA1 hippocampal subfield. Arrows indicate FJC-positive labeled neurons. Inserts showed a high magnifi-
cation (1000 ) of FJC-positive labeled neurons. N¼4 animals/group. Scale bars¼300 lm.
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p¼0.0816).3. Discussion
SE when occurred during brain development may cause acute
neurodegeneration followed by behavioral and cognitive
deficits later in life (Holmes, 1997; van Esch et al., 1996).
The acute neuronal loss induced by SE is associated with
NMDAR-mediated glutamatergic excitotoxicity whereas sev-
eral studies have reported that pretreatments with NMDAR
antagonists are effective in preventing neuronal damage
(Clifford et al., 1990; Fariello et al., 1989; Fujikawa, 1995).Nevertheless, to our knowledge there are few studies inves-
tigating the action of a post-SE onset treatment with NMDAR
antagonists on SE-induced brain consequences. In this way,
the goal of our study was to investigate the protective role of
a post-SE onset treatment with ketamine on neuronal death
and long-term behavioral alterations caused by LiCl–pilocar-
pine SE model.
Previous studies showed that a pretreatment with keta-
mine reduced intensity and duration of epileptic seizures in
metrazol, bicuculline, picrotoxin, pentylenetetrazol and elec-
trical stimulus animal models (Mikolasova et al., 1994; Velisek
et al., 1989; Veliskova et al., 1990). In our study, treatment
with ketamine after SE onset presents similar effect in both
times tested. However, latency to stop motor activity was
Fig. 2 – Profile of locomotion and exploration in open field task. Profile of distance traveled, number of animals grooming and
number of rearing across time (A, B and C, respectively). End point results of (D) locomotion time, (E) number of stops and (F)
inter-stop distance. N¼6–11 animals/group.
Fig. 3 – Effects of SE and ketamine administration in EPM. Data shows time spent in the open arms (A); number of risk
assessment behaviors (B); and number of total entries in both (open and closed) arms (C). N¼6–11 animals/group. Different
letters represent significant differences between groups. All data were analyzed by One-way ANOVA followed by Tukey post
hoc test.
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pilocarpine than those at 15 min. This apparent improved
efficacy of SEþKET60 may be related to action mechanisms of
pilocarpine, that activates muscarinic cholinergic receptors
in the seizure initiation (o30 min) but not in seizure main-
tenance and progression (460 min), which is performed
primarily by NMDAR (Fujikawa, 1995; Rice and DeLorenzo,
1998). Although we cannot exclude the possibility that keta-
mine-induced decrease of motor manifestations does not
reflect a reduction in epileptic activity on the brain, previous
studies have showed a robust relationship between electro-
encephalographic and motor activities in the LiCl–pilocarpine
SE model (Hirsch et al., 1992; Sankar et al., 1998).
In addition to reducing the severity and duration of sei-
zures, the ketamine post-SE onset treatment also signifi-
cantly reduced neurodegeneration observed in all SE-
submitted animals. Similar to previous studies (de Oliveira
et al., 2008; Sankar et al., 1998), SE induced a massive
neuronal death in several brain regions. Excessive activation
of NMDAR during SE induces a marked Ca2þ influx which canlead to metabolic derangements and subsequent neuronal
death (Hardingham et al., 2002; Holmes, 1997; Olney, 2003;
Sankar et al., 1998). Blockage of these receptors by ketamine
prevented the SE-induced neuronal death in all brain regions
from both ketamine groups (Table 1). Moreover, the metabolic
events that lead to neuronal death appear to be time-depen-
dent, whereas the ketamine-blockage of NMDAR at 15 min
after pilocarpine was more neuroprotective than that
observed at 60 min of treatment. These finding suggests that
the triggering events of neuronal death in the immature brain
occur in a time window between 15 and 60 min after SE onset.
Besides reducing seizures and neuronal death, ketamine
administration during prolonged epileptic activity also acted
against the long-term behavioral changes caused by SE. In
accordance with other studies (de Oliveira et al., 2008; Sayin
et al., 2004), SE animals showed greater anxiety levels in the
elevated plus maze (EPM) when compared with non-SE
animals. Ketamine post-SE onset treatment partially reduced
the increased anxiety-like behaviors observed in SE animals
(Fig. 3). This reduction in anxiety levels may be related to
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areas, such as hippocampus, thalamus and amygdala (Fig. 1).
Hippocampus projects to the prefrontal cortex and has some
closely connected reciprocal projections to amygdala
(Bannerman et al., 2004). Thus, both hippocampal and amyg-
dalar lesions observed after SE, may potentially be accoun-
table by altered emotionality of animals, mainly by strong
connectivity between these two limbic structures which may
have an important role in brain processes associated with
anxiety-like behaviors (Bannerman et al., 2004). In addition to
that, thalamocortical axonal projections are responsible for
conveying peripheral sensory stimuli to primary sensory
cortex (Wimmer et al., 2010). Current studies (Meyer et al.,
2010a, 2010b; Wimmer et al., 2010) show that ventral poster-
omedial thalamic nucleus (VPM) and posteromedial nucleus
(POm) projections establish vertical axon bundles in the
vibrissal cortex through two separate pathways, lemniscal
(projection arising from VPM cells) and paralemniscal (projec-
tion from POm cells) (Jones, 2002). These two pathways can
regulate the same neurons in vibrissal cortex simultaneously
(Wimmer et al., 2010). The elevated neuronal loss induced by
SE in VPM could disrupt these regulatory processes, leading to
changes in vibrissae perception, and, consequently, elevating
the expression of anxiety-like behaviors in EPM task.
Nevertheless, even if ketamine post-SE onset treatment has
completely avoided neurodegeneration, the anxiety-like
behaviors found in these animals were only partially pre-
vented, suggesting that SE can induce behavioral changes
independently of neuronal death. Previous works using a
model of febrile seizures found physicochemical alterations
in hippocampal and amygdalar neurons which were not
accompanied by significant DNA fragmentation (Bender
et al., 2003; Chen et al., 2001; Dube et al., 2000). In addition,
Hoffmann et al. (2004) observed cognitive impairment in the
water maze test in the LiCl–pilocarpine model even in
absence of cell loss. In our study, ketamine-blockage of
NMDAR in non-SE young rats resulted in enhanced anxiety
levels later in life, which adds further support to the hypoth-
esis that emotional behavioral changes can occur separately
of neuronal death.
Long-term consequences, such as altered emotionality,
caused by ketamine in non-SE rats can be related to ketamine
influence on physiological pathways. Blockage of NMDAR in
normal conditions can affect physiological processes such as
long-term responses and neural plasticity. A recent study
observed pro-oxidant effects of ketamine on the central
nervous system after a single ketamine administration which
may be related to anxiety-like behaviors (da Silva et al., 2010).
However, more investigations are needed to unravel the
mechanisms that mediate these effects.
In the open field task, we evaluated the spatio-temporal
profile of locomotion and exploitation of animals in order to
identify the strategies used by them in exploring a new
environment. In agreement with de Oliveira et al. (2008), we
did not find any difference among groups in the locomotor
and exploratory activities as well as in temporal and spatial
organization of behavior. These findings strengthen the
hypothesis of an increase in levels of anxiety induced by SE
in EPM, demonstrating that changes in anxiety-like behaviors
are not due to differences in exploratory strategies.In summary, we have shown in this study that ketamine
intervention is able to prevent SE-induced neuronal death in
young rats. Moreover, ketamine prevented the anxiogenic
effect of SE in adult rats submitted to prolonged epileptic
activity early in life. These findings suggests that ketamine
was effective in prevent excessive neuronal activity, abnor-
mal, and hypersyncronic, thereby avoiding the evolution of
the seizure pattern. Moreover, our results suggests possible
adverse effects of ketamine alone, and more studies are
needed to understand these effects.4. Experimental procedure
4.1. Materials
Pilocarpine hydrochloride was purchased from Sigma-Aldrich
(USA), ketamine hydrochloride was purchased from Agener
Uni ~ao (Brazil), and Fluoro-Jade C was purchased from Che-
micon, Inc. (USA). Other chemicals were purchased from
Nuclear (Brazil).4.2. Subjects
Sixty-one male young Wistar rats (15 postnatal days—PND15)
were obtained from local breeding. The litters were culled to 7
pups. The day of birth was defined as day 0 and the animals
were weaned on PND21. After weaning, animals were housed
in standard polypropylene cages in groups of 4–5 animals
with food and water ad libitum. Animals were maintained
under a 12 h controlled light/dark photoperiod cycle (lights on
at 7:00 a.m) with the room temperature adjusted to 2172 1C.
The handling and care of animals were conducted according
to the Guide for Care and Use of Laboratory Animals from
National Institutes of Health. All procedures were approved
by the Ethic Committee from Universidade Federal do Rio
Grande do Sul (protocol number 2008058).4.3. Induction of status epilepticus
Rat pups were injected with a solution of LiCl (3 mEq/kg i.p.)
12–18 h prior to pilocarpine (60 mg/kg i.p.—SE group) admin-
istration on PND16 (de Oliveira et al., 2008). The volume of
injection was 10 ml/kg. Control animals were handled and
housed in the same manner as experimental animals and
received an equal volume of saline (0.9% NaCl i.p.—CTRL
group) or ketamine (22.5 mg/kg i.p.—KET group). Fifteen
(SEþKET15 group) or 60 min (SEþKET60 group) after pilocar-
pine administration, pups received ketamine (22.5 mg/kg i.p.).
Rats were put in individual plastic cages at 34 1C (nest
temperature) for observation of seizures during 3 h. The
manifestation of SE was evaluated only by behavioral mea-
sures. Rats were allowed to spontaneously recover from SE.
The body weight was assessed daily until the weaning. Each
experimental group contained pups from several litters. After
SE induction, animals were divided into two main subsets.
The first subset was used to determine the SE-induced
neuronal loss (Fluoro-Jade C staining) and the second subset
was submitted to behavioral tasks in adulthood. According to
b r a i n r e s e a r c h 1 4 7 4 ( 2 0 1 2 ) 1 1 0 – 1 1 7 115data obtained by Priel et al. (1996), the occurrence of sponta-
neous seizures in adult rats was not monitored.
4.4. Fluoro-Jade C staining
The FJC staining was performed as described by Schmued
et al. (2005). Briefly, 24 h after SE induction rats were deeply
anesthetized i.p. with ketamine (90 mg/kg) and xylazine
(12 mg/kg) and sequentially perfused through the heart with
200 mL of ice-cold 0.1 M sodium phosphate buffer, pH 7.4,
followed by 100 mL of ice-cold fixative solution 4% parafor-
maldehyde in 0.1 M sodium phosphate buffer, pH 7.4. Brains
were removed and immersed overnight in fixative solution
followed by 30% sucrose until the brains sank to the bottom
of the chamber. Coronal slices (30-mm) were obtained using a
Leica VT1000S vibroslicer and mounted onto gelatin-coated
slides and dried at room temperature overnight. For staining,
slides were immersed in a basic alcohol solution consisting of
1% sodium hydroxide in 80% ethanol for 5 min. They were then
rinsed for 2 min in 70% ethanol, 2 min in distilled water, and
then incubated in 0.06% potassium permanganate solution for
10 min. After rinsing with distilled water for 2 min, the slides
were then transferred for 10 min to a 0.0001% FJC solution
dissolved in 0.1% acetic acid, washed three times for 1 min with
destilled water, dried at room temperature overnight, dehy-
drated in xylene, and cover slipped. Sections were analyzed
using a Nikon Eclipse E600 epi-fluorescence microscope.
Cell counts for FJC-positive neuronal cells were performed in
coronal brain sections on representative microscopic fields
corresponding to plate 32 of Paxinos and Watson (1998). Areas
of interest were demarcated using the software NIS-Elements
Version 3.10 (Nikon Instruments Inc., USA), and the number of
neurons were counted by the same software. According to
Wang et al. (2008), cells exhibiting bright green fluorescence and
profiles of neuronal somas were counted while FJC-positive
fragments were not counted.
4.5. Behavioral procedures
Open-field and EPM tasks were carried out on PND75–77 and
PND80, respectively. Before each behavioral task, rats were
placed in the test room (temperature 2172 1C) for one hour to
allow habituation with the environment and researcher. All
tasks were performed between 1:00 and 6:00 p.m. The
behavior was recorded and analyzed using the ANY-Maze
video-tracking system (Stoelting, CO). Between each trial,
apparatuses were cleaned with ethanol 70%.
4.6. Open field
Open field was performed in order to identify the strategies
used by animals in exploring a new environment. The test
consisted of a circular wooden black arena of 6050 cm
(diameterheight). The floor of the apparatus was virtually
divided into 28 squares (12 central and 16 peripheral). The
testing room was illuminated by two lamps directed to the
ceiling. The light intensity was 15 lx in the center of the
arena. Each animal was individually placed in the periphery
of the arena and was left free to explore it for 15 min. Based
on studies performed by Eilam (2003) and Li et al. (2010),spatio-temporal organization of locomotor and exploratory
activities were quantified as follows:
4.6.1. Level of locomotor and exploratory activities:
(a) Total number of rearing and grooming. (b) Distance
traveled: overall distance that animals traveled during the
15 min observation. (c) Locomoting time: overall duration of
locomoting periods, during which animals accumulated the
traveled distance. (d) Number of stops: the incidence of ‘‘non-
locomoting’’ intervals that were bound by ‘‘locomoting’’
intervals. (e) Inter-stops distance: the metric distance tra-
veled between two consecutive stops (total distance divided
by total number of stops).
4.6.2. Temporal organization of locomotion
(a) Number of trips: by ranking squares (places) according to
the accumulated ‘‘non-locomoting’’ intervals, the place with
the highest rank was termed ‘‘home-base’’. Intervals between
consecutive stops at home-base were scored as ‘‘trips’’ to the
arena. (b) Trip length: metric distance traveled in a round-trip
(¼total distance divided by total number of trips). (c) Stops/
trip: number of stops taken between two successive stops at
the home-base (¼total number of stops divided by total
number of trips).
4.6.3. Spatial distribution
(a) Distance traveled along the perimeter: traveled distance along
the vicinity of the walls of the arena. (b) Locomoting time spent
along the perimeter: traveling time along the vicinity of the
walls of the arena. (c) Time spent on home-base.
4.7. Elevated plus maze
EPM was used to assess anxiety-like behaviors. The maze
consisted of two open arms (5010 cm) and two closed arms
(501040 cm) with the arms of each type opposite to each
other. The maze was elevated to a height of 50 cm off the
floor. The experiment was conducted in a room illuminated
by red light. The light intensity at the center of the apparatus
was 5 lx. Rats were placed in the maze center facing the open
arm and they were left free to explore the apparatus for
5 min. The following parameters were analyzed:
4.7.1. Anxiety levels
(a) Time spent in the open arms. (b) Number of risk assessment
behaviors: number of times at exploration of the open arm
through stretch-attend posture (when the rodent is motion-
less in center- or closed-zone, but has its body stretched
forward into the open arms by placing some but not all paws,
returning then to the same position).
4.7.2. Exploratory activity in the apparatus
Total number of entries in both open and closed arms.
4.8. Statistical analysis
All data were expressed as mean7S.E.M. and were analyzed
by One-way ANOVA followed by the Tukey’s Multiple Com-
parison post hoc test for unequal samples. Po0.05 was
considered significantly.
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